-
Mashup Score: 0
In a head-to-head comparison in the FLAVOUR trial, IVUS- and FFR-guided PCI produced similar outcomes but had differing strengths.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Benefit of SubQ Arrhythmia Monitoring Post-MI May Hinge on Risk - 2 year(s) ago
Drs Jagmeet Singh and Christian Jøns discuss results of the BIO|GUARD-MI study that used an insertable cardiac monitor to track arrhythmias in post-MI patients to see if treating them improved outcomes.
Source: MedscapeCategories: Cardiologists, Latest HeadlinesTweet-
Great conversation with Dr. Jons on late breaker BIOGUARD-MI at #ACC2022 SubQ Arrhythmia (Loop) Monitoring in Post-MI patients with preserved LVEF is useful in NSTEMI group! @theheartorg @MassGenBrigham @MGHHeartHealth https://t.co/eLDMm55j93
-
-
Mashup Score: 0Empagliflozin rapidly improves acute heart failure symptoms in hospitalized patients - 2 year(s) ago
Empagliflozin showed symptomatic benefits in patients hospitalized for acute heart failure after 2 weeks in a secondary analysis from the EMPULSE trial.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Empagliflozin rapidly improves acute heart failure symptoms in hospitalized patients. https://t.co/LURX8zwPLa #ACC2022 https://t.co/Wd4B2H6yOv
-
-
Mashup Score: 0Extreme heat drives CV death risk in men, Black adults - 2 year(s) ago
WASHINGTON — A greater number of extreme heat days was associated with elevated CV mortality in men and Black adults across the United States from 2008 to 2017, researchers reported at the American College of Cardiology Scientific Session.“This suggests that extreme heat may have a disproportionate impact on the cardiovascular health of certain populations,” Sameed Khatana MD,
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: “This suggests that extreme heat may have a disproportionate impact on the cardiovascular health of certain populations,” #ACC2022 @SameedKhatana @ACCinTouch #ACC22 #ACCNews #CardioTwitter https://t.co/puQnLbKNrY
-
-
Mashup Score: 2SCORED: Sotagliflozin shows robust MACE benefit - 2 year(s) ago
Trial results in patients with diabetes, CKD, and high CVD risk showed robust benefits across MACE outcomes, distinguishing sotagliflozin from the SGLT2 inhibitors.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
SCORED: #Sotagliflozin shows robust MACE benefit. https://t.co/oZwfZ7pH2M #ACC2022 https://t.co/WJhItLTWmN
-
-
Mashup Score: 2Extreme heat drives CV death risk in men, Black adults - 2 year(s) ago
WASHINGTON — A greater number of extreme heat days was associated with elevated CV mortality in men and Black adults across the United States from 2008 to 2017, researchers reported at the American College of Cardiology Scientific Session.“This suggests that extreme heat may have a disproportionate impact on the cardiovascular health of certain populations,” Sameed Khatana MD,
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: “This suggests that extreme heat may have a disproportionate impact on the cardiovascular health of certain populations,” #ACC2022 @SameedKhatana @ACCinTouch #ACC22 #ACCNews #CardioTwitter https://t.co/puQnLbKNrY
-
-
Mashup Score: 1Extreme heat drives CV death risk in men, Black adults - 2 year(s) ago
WASHINGTON — A greater number of extreme heat days was associated with elevated CV mortality in men and Black adults across the United States from 2008 to 2017, researchers reported at the American College of Cardiology Scientific Session.“This suggests that extreme heat may have a disproportionate impact on the cardiovascular health of certain populations,” Sameed Khatana MD,
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A greater number of extreme heat days was associated with higher CV death among men and Black adults across the U.S. from 2008 to 2017, researchers reported at #ACC2022 @SameedKhatana @ACCinTouch #ACC22 #ACCNews #CardioTwitter https://t.co/puQnLbtc3o
-
-
Mashup Score: 0TAVI device shows less deterioration than surgery 5 years out - 2 year(s) ago
A transcatheter aortic valve – CoreValve Evolut – is associated for first time with less deterioration than surgical repair at 5 years.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
TAVI device shows less deterioration than surgery 5 years out. https://t.co/1kjTyOkACA #ACC2022 https://t.co/ft1BIWFSh7
-
-
Mashup Score: 1Early PCSK9 inhibition in AMI yields plaque regression - 2 year(s) ago
‘Go early and go low’ is an expert’s response to the imaging results from PACMAN-AMI showing plaque reduction after AMI patients received alirobumab.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Early PCSK9 inhibition in AMI yields plaque regression. https://t.co/OxhnHlogev #ACC2022 https://t.co/0CwcKqmHFj
-
-
Mashup Score: 0Anticoagulation not routinely needed after TAVR: ADAPT-TAVR - 2 year(s) ago
The ADAPT-TAVR trial showed a numerical reduction in leaflet thrombosis with edoxaban versus dual-antiplatelet therapy, but no reduction in cerebral events or neurocognitive function.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Anticoagulation not routinely needed after TAVR: ADAPT-TAVR. https://t.co/7STtobYDZx #ACC2022 https://t.co/hY5V8oltWC
-
FFR is not better, just different from IVUS for revascularizing intermediate stenosis. https://t.co/nHf6ezVbB4 #ACC2022 https://t.co/ZtngRf51ta